Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

Alphabet Inc.’s Google has deepened its commitment to artificial intelligence (AI) by investing an additional $1 billion in ...

European banks are on the up and up. And President Donald Trump has thrown spikes on the road for US climate policy. Plus, mining companies in Africa’s Sahel region are being targeted. Aanu Adeoye ...

Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.

Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...